- Home
- OGS vs ALKS Comparison
OGS vs ALKS Comparison
Compare OGS & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGS
- ALKS
- Stock Information
- Founded
- OGS 1906
- ALKS 1987
- Country
- OGS United States
- ALKS Ireland
- Employees
- OGS N/A
- ALKS N/A
- Industry
- OGS Oil/Gas Transmission
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- OGS Utilities
- ALKS Health Care
- Exchange
- OGS Nasdaq
- ALKS Nasdaq
- Market Cap
- OGS 4.9B
- ALKS 5.0B
- IPO Year
- OGS N/A
- ALKS 1991
- Fundamental
- Price
- OGS $80.90
- ALKS $31.48
- Analyst Decision
- OGS Buy
- ALKS Strong Buy
- Analyst Count
- OGS 7
- ALKS 13
- Target Price
- OGS $80.36
- ALKS $42.31
- AVG Volume (30 Days)
- OGS 320.5K
- ALKS 2.3M
- Earning Date
- OGS 11-03-2025
- ALKS 10-28-2025
- Dividend Yield
- OGS 3.33%
- ALKS N/A
- EPS Growth
- OGS 6.57
- ALKS 2.44
- EPS
- OGS 4.21
- ALKS 2.02
- Revenue
- OGS $2,330,032,000.00
- ALKS $1,521,338,000.00
- Revenue This Year
- OGS $23.73
- ALKS N/A
- Revenue Next Year
- OGS $4.31
- ALKS $1.59
- P/E Ratio
- OGS $19.11
- ALKS $15.59
- Revenue Growth
- OGS 13.43
- ALKS 1.08
- 52 Week Low
- OGS $66.38
- ALKS $25.17
- 52 Week High
- OGS $83.39
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- OGS 51.67
- ALKS 57.72
- Support Level
- OGS $80.17
- ALKS $28.47
- Resistance Level
- OGS $83.39
- ALKS $31.90
- Average True Range (ATR)
- OGS 1.26
- ALKS 1.28
- MACD
- OGS -0.26
- ALKS -0.08
- Stochastic Oscillator
- OGS 34.90
- ALKS 76.46
About OGS ONE Gas Inc.
ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. The company controls considerable market shares in Oklahoma and Kansas.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.